Skip to NavigationSkip to content

Pharmafile - Research and Development News

Scientists have been voicing concern that a lack of transparency from the therapy’s developers could impact the successful roll out if it eventually...
Fujifilm is now expected to forge ahead in securing regulatory approval in Japan and around the world. The company said it aims to submit a...
The FDA is set to release new guidelines that would raise safety and efficacy requirements required for a COVID-19 vaccine to be granted Emergency...
Public Health England has warned that catching seasonal flu and coronavirus at the same time could almost double the risk of death.
The coronavirus news this week largely focuses on clinical trial results, with Pfizer saying that participants in a late-stage trial for its COVID-19...
The data revealed that, after a median of five years following initial treatment, patients who received Keytruda showed an overall survival (OS) rate...
In the first study, the combo was found to generate an objective response rate of 21.4% in the treatment of unresectable or advanced melanoma which...
Dr Susanne Schaffert, President of Novartis Oncology said: “These data demonstrating survival benefit give the 40% of HR+/HER2- advanced breast...
The results mark an improvement in overall response compared to data shared on the drug in this indication back in May, and no new safety signals...
Russian Minister of Health Mikhail Murashko told journalists on 15 September that, so far, more 300 people have been vaccinated with Sputnik V, with...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches